McKenna Mark C.
CIK: 0001749623
Director
Primary company: Prometheus Biosciences, Inc. (RXDX)
McKenna Mark C. is a corporate insider at Prometheus Biosciences, Inc. (RXDX) filing SEC Form 4 transactions. 61 transactions across 6 companies, totaling $990,775 in purchases and $15,223,652 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Freenome, Inc. FRNM | Conversion | 30,000 | - | - | 0 | 7/20/2026 Filed: 7/20/2026 | Filing → |
Freenome, Inc. FRNM | Conversion | 30,000 | - | - | 30,000 | 7/20/2026 Filed: 7/20/2026 | Filing → |
| Award | 7,657 | $85.00 | $651K | 7,657 | 6/9/2026 Filed: 6/9/2026 | Filing → | |
| Award | 8,026 | $72.51 | $582K | 8,026 | 5/27/2026 Filed: 5/27/2026 | Filing → | |
| Exercise | 30,000 | - | - | 0 | 8/11/2025 Filed: 8/11/2025 | Filing → | |
| Exercise | 30,000 | - | - | 30,000 | 8/11/2025 Filed: 8/11/2025 | Filing → | |
| Award | 14,461 | - | - | 14,461 | 6/17/2025 Filed: 6/20/2025 | Filing → | |
| Award | 25,000 | - | - | 25,000 | 5/29/2025 Filed: 6/2/2025 | Filing → | |
NewAmsterdam Pharma Co N.V. NAMS | Award | 6,960 | - | - | 6,960 | 1/7/2025 Filed: 1/8/2025 | Filing → |
NewAmsterdam Pharma Co N.V. NAMS | Award | 32,500 | $25.85 | $840K | 32,500 | 1/6/2025 Filed: 1/8/2025 | Filing → |
| Purchase | 12,500 | $49.85 | $623K | 20,000 | 12/12/2024 Filed: 12/16/2024 | Filing → | |
| Purchase | 7,500 | $49.02 | $368K | 7,500 | 12/12/2024 Filed: 12/16/2024 | Filing → | |
NewAmsterdam Pharma Co N.V. NAMS | Award | 72,500 | - | - | 72,500 | 7/17/2024 Filed: 7/19/2024 | Filing → |
| Award | 10,370 | - | - | 10,370 | 6/5/2024 Filed: 6/7/2024 | Filing → | |
| Award | 40,000 | - | - | 40,000 | 2/1/2024 Filed: 2/5/2024 | Filing → | |
| Award | 100,000 | $0.00 | $0 | 150,000 | 8/17/2023 Filed: 8/21/2023 | Filing → | |
| Award | 50,000 | $0.00 | $0 | 50,000 | 8/17/2023 Filed: 8/21/2023 | Filing → | |
Prometheus Biosciences, Inc. RXDX | Disposition | 128,930 | - | - | 0 | 6/16/2023 Filed: 6/16/2023 | Filing → |
Prometheus Biosciences, Inc. RXDX | Disposition | 246,639 | - | - | 0 | 6/16/2023 Filed: 6/16/2023 | Filing → |
Prometheus Biosciences, Inc. RXDX | Disposition | 290,000 | - | - | 0 | 6/16/2023 Filed: 6/16/2023 | Filing → |
Freenome, Inc.
FRNM
Type
Conversion
Shares
30,000
Price
-
Value
-
Freenome, Inc.
FRNM
Type
Conversion
Shares
30,000
Price
-
Value
-
Type
Award
Shares
7,657
Price
$85.00
Value
$651K
Type
Award
Shares
8,026
Price
$72.51
Value
$582K
Type
Exercise
Shares
30,000
Price
-
Value
-
Type
Exercise
Shares
30,000
Price
-
Value
-
Type
Award
Shares
14,461
Price
-
Value
-
Type
Award
Shares
25,000
Price
-
Value
-
NewAmsterdam Pharma Co N.V.
NAMS
Type
Award
Shares
6,960
Price
-
Value
-
NewAmsterdam Pharma Co N.V.
NAMS
Type
Award
Shares
32,500
Price
$25.85
Value
$840K
Type
Purchase
Shares
12,500
Price
$49.85
Value
$623K
Type
Purchase
Shares
7,500
Price
$49.02
Value
$368K
NewAmsterdam Pharma Co N.V.
NAMS
Type
Award
Shares
72,500
Price
-
Value
-
Type
Award
Shares
10,370
Price
-
Value
-
Type
Award
Shares
40,000
Price
-
Value
-
Type
Award
Shares
100,000
Price
$0.00
Value
$0
Type
Award
Shares
50,000
Price
$0.00
Value
$0
Prometheus Biosciences, Inc.
RXDX
Type
Disposition
Shares
128,930
Price
-
Value
-
Prometheus Biosciences, Inc.
RXDX
Type
Disposition
Shares
246,639
Price
-
Value
-
Prometheus Biosciences, Inc.
RXDX
Type
Disposition
Shares
290,000
Price
-
Value
-
AI Agent
Try asking...